Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn’s Disease in China

被引：0
|
作者：
Ting Zhou
Yanan Sheng
Haijing Guan
机构：
[1] China Pharmaceutical University,School of International Pharmaceutical Business
[2] Takeda (China) International Trading Company,Medical Affairs
[3] Beijing Tiantan Hospital,Department of Pharmacy
[4] Capital Medical University,undefined
[5] China Center for Health Economic Research,undefined
[6] Peking University,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
China; Conventional therapy; Cost-effectiveness analysis; Crohn’s disease; Vedolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4233 / 4245
页数：12
相关论文
共 50 条
  • [1] Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn's Disease in China
    Zhou, Ting
    Sheng, Yanan
    Guan, Haijing
    [J]. ADVANCES IN THERAPY, 2021, 38 (08) : 4233 - 4245
  • [2] Cost-Effectiveness of Reimbursing Infliximab for Moderate to Severe Crohn's Disease in China
    Chen, Haotian
    Shi, Jihao
    Pan, Yipeng
    Zhang, Zhou
    Fang, Hao
    Chen, Ying
    Chen, Wendong
    Cao, Qian
    [J]. ADVANCES IN THERAPY, 2020, 37 (01) : 431 - 449
  • [3] Cost-Effectiveness of Reimbursing Infliximab for Moderate to Severe Crohn’s Disease in China
    Haotian Chen
    Jihao Shi
    Yipeng Pan
    Zhou Zhang
    Hao Fang
    Ying Chen
    Wendong Chen
    Qian Cao
    [J]. Advances in Therapy, 2020, 37 : 431 - 449
  • [4] COST-EFFECTIVENESS ANALYSIS OF BIOSIMILARS BASED TREATMENT SEQUENCES FOR MODERATE-TO-SEVERE CROHN DISEASE IN SPAIN
    Fernandez Santos, J. M.
    Monte Boquet, E.
    Borras Blasco, J.
    Romero de la Cruz, E.
    Gonzalez Galan, R.
    Singh, M. K.
    Sharma, V
    Merino-Bohorquez, V
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S362 - S362
  • [5] COST-EFFECTIVENESS OF VEDOLIZUMAB FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS IN THAILAND
    Sruamsiri, R.
    [J]. VALUE IN HEALTH, 2018, 21 : S2 - S2
  • [6] Cost-effectiveness of treatment for moderate-to-severe psoriasis
    Hankin, CS
    Feldman, SR
    Pearce, D
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 654 - 654
  • [7] Cost-effectiveness of tacrolimus for the treatment of moderate-to-severe lupus nephritis in China
    Kim, Soyoung
    Ooi, Adrian Yit Reen
    Stephens, Thomas
    Jiang, Hongsi
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (13) : 1125 - 1141
  • [8] Cost-effectiveness of ustekinumab in moderate to severe Crohn's disease in Sweden
    Hansson-Hedblom, Amanda
    Almond, Chrissy
    Borgstrom, Fredrik
    Sly, Indeg
    Enkusson, Dana
    Buchholt, Anders Troelsgaard
    Karlsson, Linda
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2018, 16
  • [9] Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden
    Amanda Hansson-Hedblom
    Chrissy Almond
    Fredrik Borgström
    Indeg Sly
    Dana Enkusson
    Anders Troelsgaard Buchholt
    Linda Karlsson
    [J]. Cost Effectiveness and Resource Allocation, 16
  • [10] Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands
    Hoogveldt, Bart
    Rive, Benoit
    Severens, Johan
    Maman, Khaled
    Guilhaume, Chantal
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 313 - 317
12345